Fuculose-1-phosphate aldolase (FucA) has been produced in E.coli as active inclusion bodies (IBs) in batch cultures. The activity of insoluble FucA has been modulated by a proper selection of the producing strain, culture media and process conditions. In some cases, when an optimized defined medium was used, FucA IBs were more active (in terms of specific activity) than the soluble protein version obtained in the same process with a conventional defined medium, giving credit to the concept that solubility and conformational quality are independent protein parameters. FucA IBs have been tested as biocatalysts, either directly or immobilized into Lentikat® beads, in an aldolic reaction between DHAP and (S)-Cbz-alaninal, obtaining product yields ranging from 65 to 76 %. The production of an active aldolase as IBs, the possibility of tailoring IBs properties by both genetic and process approaches and the reusability of IBs by further entrapment in appropriate matrices fully support the principle of using self-assembled enzymatic clusters as tunable mechanically stable and functional biocatalysts.
INTRODUCTION
Aldolases are C-C bond forming enzymes with widespread applications. Stereoselective C-C bond catalysis by aldolases has been reported as an attractive alternative to conventional chiral organic chemistry methods for chemical and pharmaceutical industries. Aldolases catalyze C-C bond formation with defined stereochemistry yielding enantiomerically pure products, even when the starting materials are non-chiral substrates 1 . Fuculose-1-phosphate aldolase (FucA) is one of the four enzymes of the dihydroxyacetone phosphate (DHAP) dependent aldolase group, together with fructose-1,6-diphosphate, tagatose-1,6-diphosphate aldolase and rhamnulose-1-phosphate aldolase. These enzymes have been used as catalysts for the synthesis of enzyme inhibitors such as iminocyclitols, which have been largely investigated as therapeutic targets for the design of new antibiotics, antimetastic, antihyperglycemic or immunostimulatory agents [2] [3] [4] . Specifically, fuculose-1-phosphate aldolase catalyses the selective formation of R-R diols (D erythro compounds) by means of an aldol addition between DHAP and a wide variety of aldehydes. These aminopolyols are precursors of biologically active iminocyclitols 5, 6 . FucA has been produced as a soluble recombinant fusion protein in Escherichia coli with a six-histidine tag under the control of isopropyl-D-thiogalactopyranoside (IPTG) inducible promoter trc 7 .
Interestingly, some recent studies have demonstrated that, under certain circumstances, proteins can be produced as biologically active inclusion bodies (IBs) [8] [9] [10] [11] [12] [13] observing that the conformational quality of proteins embedded in such aggregates is not significantly lower compared to their soluble counterparts. Moreover, these protein aggregates, can be easily recovered and purified from disrupted bacterial cells and employed, directly or in an immobilized form, as biocatalysts for bioprocess industry. In addition, it has been observed that the conformation quality of IBs produced in E.coli strains in absence of the main cytoplasmic chaperone DnaK is enhanced 17, 18 . In fact, DnaK has not only an important role in the control of the distribution of functional protein species between soluble and insoluble cell fractions, but it also controls protein degradation, being the IBs formed larger and more biologically active than those formed in wild type strains 17 .
The aim of this work is to demonstrate, as proof of concept, that enzymes like aldolases expressed as active IBs can be useful biocatalysts in synthesis reactions, since these aggregates are highly pure (most of IB biomass is expected to be the target protein), easy to produce and purify and even, they can be (re)used in immobilized form. At present, although some enzymes have been utilized in its aggregated form to catalyze reactions 16 , it is still necessary to obtain more information about the conditions of active IBs production as well as the preparation and use of efficient IB-derived biocatalysts. In this sense, IBs can be employed directly or entrapped into particles (like Lentikats®, polyvinyl alcohol derived beads) in order to improve their mechanical and handling properties.
Therefore, we investigated here the conditions for the expression of FucA in active IBs and their characterization. On the other hand, the objectives include the preparation of IB-derived biocatalysts and their use in the stereoselective aldol addition between DHAP and (S)-Cbz-alaninal.
MATERIALS AND METHODS

Bacterial strains and vectors
The fucA gene from Escherichia coli was expressed from a pTrcHis-based vector called pTrcfuc (Invitrogen, San Diego, USA) in Escherichia coli XL-1-Blue and JGT20 (Table   4   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25 1 2 1). pTrcHis expression system is a commercial vector designed to express high levels of non-toxic proteins in E.coli under the control of trc expression promoter. The protein is produced with an N-terminal fused His6-tag.
In M15∆GlyA pQEαβT1fucA, the gene was expressed from pQEαβT1fucA ( Fig.1) , a pQE40-based plasmid (Qiagen) which was used to produce fuculose-1-phosphate aldolase in E. coli . It contains a bla gene, the fucA gene, a ColEI replication origin and a strong promoter T5. Furthermore, an rrnT1B terminator was introduced to ensure a better regulation (Sans et al., unpublished work).
Media and growth conditions
At small scale, bacterial cells were cultured in shake flask employing Luria-Bertani 
Inclusion bodies purification
The E. coli cells were harvested after cultivation by centrifugation for 15 min at 15,000 g, and the pellet stored at -80ºC. For sample processing, it was resuspended in lysis buffer (100 mM Tris-HCl, 150 mM KCl pH 7.5) at a ratio of 3 mL/ g dry cell weight (DCW). Besides, 15µL/g DCW of the proteases inhibitor phenylmethylsulfonyl fluoride (PMSF) were added from a 100 mM stock, followed by 80µL/ g DCW of lyzozyme from a 10 mg/ml stock, and the mixture incubated at 37ºC with shaking during 30-45 min. Later, nonylphenoxypolyethoxylethanol (NP-40) was added to a final concentration of 1% (v/v) and the mixture incubated at 4ºC for 30-45 min, followed by the addition of DNAse I (25 µL from a 1 mg/mL stock) and MgSO 4 (at a final concentration of 10 mM). After incubation with shaking at 37ºC for 30-45 min, the lysate was centrifuged at 15,000 g for 15 min and the supernatant was stored at -80ºC for further analysis of the soluble cell fraction.
The obtained pellet containing IBs, was washed by resuspension in 1 mL lysis buffer with Triton (2%) at 4ºC for 30-45 min followed by centrifugation for 15 min at 15000 g.
The process was repeated several times until residual enzymatic activity was fully eliminated from the supernatant. The final pellet was stored at -80ºC.
Protein quantification
SDS-PAGE gels at 12% were prepared using MiniProtean II (Bio-Rad Laboratories Inc, California) equipment according to the manufacturer's instructions. Gels were stained Protein concentration was determined with the Coomassie protein assay reagent kit (Pierce, Rockford, Ill, USA), using BSA as standard.
FucA enzymatic assay
Fuculose-1-phosphate aldolase activity was determined as previously reported 21 for both soluble and IBs enzyme. One unit of activity (AU) was defined as the amount of enzyme required to transform 1 µmol of fuculose-1-phosphate per minute at 25ºC under the assay conditions. The spectrophotometric measurement was performed with a Varian 300 spectrophotometer. For IBs activity determination, a stirred cuvette was employed to ensure sample homogeneity. Fuculose-1-phosphate was synthesized as dicyclohexylamine salt according to reported procedures 21 .
Inclusion body immobilisation in Lentikat®
Entrapment of IBs in Lentikats ® was performed according to the protocol provided by shape and size of droplets. 22 . Lentikat® stabilizer solution was then poured into the gel particles for particle re-swelling and the whole mixture stirred for two hours. The lensshaped particles were thoroughly washed with lysis buffer for two hours, filtered and weighted after removal of excess buffer, and either immediately used for bioconversion runs or stored at 4ºC until use.
FucA catalyzed aldol addition
The reaction between DHAP and (S)-Cbz-alaninal consisted of an aldol addition leading to the following product: (3R, 4R, 5S)-5-(benzyloxycarbonylamino-5,6-dideoxy-1-Ophosphonohex-2-ulose). Dihydroxyacetone phosphate dilithium salt (DHAPLi 2 ) was purchased from Fluka (Seelze, Germany).
(S)-Cbz-alaninal was synthesized in our laboratory by 2-iodobenzoic acid oxidation of the corresponding N-protected amino alcohol as reported in literature 21 .
In order to ensure solubility of both substrates, dimethylformamide (DMF) was required as cosolvent. All aldol reactions were performed at 4ºC at initial concentrations of 25 mM DHAP and 42.5 mM (S)-Cbz-alaninal in 20% (v/v) DMF: 50 mM Tris-HCl, 150mM KCl pH=7 21 . DHAP substrate was previously dissolved in aqueous buffer, whereas (S)-Cbz alaninal was dissolved in DMF. Reaction started after addition of the proper biocatalyst suspension to get the desired FucA activity (see Table 4 ) in a final reaction volume of 2.5 or 10 mL. The progress of the reaction was followed by measuring product, DHAP and (S)-Cbz-alaninal concentration evolution with time. 
RESULTS AND DISCUSSION
Two different expression systems were available in our laboratory for soluble FucA production (see Materials and Methods for details). In the first one, FucA was expressed in E.coli XL1 Blue driven by the plasmid pTrcFucA. No IBs were detected during growth at 37ºC, after induction of gene expression by 100 µM IPTG 23 . In the second one, the E. coli K-12 derived strain M15 ΔglyA, harboring a low copy number plasmid from pQE-40 (Qiagen), was used for soluble FucA overexpression. This is a glycine auxotrophy-based system to ensure plasmid stability which avoids the need of antibiotic supplementation 24 . Transcription of the gene under the control of the strong T5 promoter resulted in higher soluble aldolase activities than the first strain, working at the same conditions, without significant IBs formation (unpublished results).
Formation of active FucA inclusion bodies from XL1 Blue and JGT20
In order to investigate the feasibility of FucA expression as active IBs, as a first approach, the plasmid pTrcfucA was transformed in E. coli JGT20, a DnaK IBs with aldolase activity were observed in all cases (Table 2) , being the amount of active enzyme per gram of dry cell weight (DCW) in the dnaK mutant much higher than in E. coli XL1 Blue, at both temperatures.
In XL1 Blue, the levels of soluble FucA were, according to previous work, around 280 AU/g DCW 7 , and only a reduced fraction of FucA (around 2 %) was detected in the IBs at both temperatures. In the case of JGT20, higher protein amounts were observed in soluble and in insoluble forms. Soluble levels reached more than 2000 AU/g DCW, and the IBs fraction represented around 4% of the total recombinant protein at 37ºC, and only 2% at 42º C.
In XL1 Blue, the specific activity (AU/mg protein) of IBs was higher at 42ºC than at 37ºC with a maximum value of around 3 AU/mg (data not shown). The purity of the IBs was relatively low in both cases, as only 25-30% of the total IBs protein corresponded to full-length FucA (data not shown).
Concerning the dnaK background, data are shown in Figure 2 for 37ºC growth (final biomass concentration 1.6 g/L) and 42ºC (final biomass concentration 0.6 g/L). The JGT20 strain rendered higher values of FucA specific activity than the XL1 Blue strain at 37ºC, as 6 AU/mg of target protein were found in IBs. These results are in accordance to the suggestion that active IBs can have equal or higher specific activity than the soluble fraction 11, 14 as it has been reported that misfolds may be more abundant sometimes in the soluble than the more dense IB fraction 11 . It has to be noticed that the increase of temperature to 42ºC had a negative effect on the activity of IBs FucA in JGT20. In fact, it has been reported that at lower temperatures, The IBs in JGT20 were of higher purity than in XL-1-Blue, as 70% of protein in IBs was recombinant aldolase at both temperatures. Consequently, the results demonstrate that JGT20 is able to render active FucA IBs. Nevertheless, although specific activity and purity at 37ºC were good enough, the feasibility of using JGT20 strain in the presented conditions for FucA expression in IBs was very compromised by the low yield (only 4% of total enzyme in IB).
A possible improvement of IBs yield could be eventually reached by changing the expression strain and/or employing different growth conditions 27, 28 . The use of an optimized defined medium (see Materials and Methods) did not improve the yield of active inclusion bodies in JGT20 strain. Consequently, different expression strains were tested.
Inclusion body production with M15∆GlyApQEαβT1fucA strain.
The auxotrophy-based system (strain M15∆GlyApQEαβT1fucA) was also evaluated for FucA production in form of IBs. This strain had been employed for soluble RhuA and FucA production in high-cell density cultures, giving around 1000 AU/g DCW 24 (unpublished results). The most relevant features of this strain are given in the Materials and Methods section.
Growth of the above strain and FucA IBs formation were studied in shake flasks experiments. In LB medium, the expression was again mainly in soluble form as for JGT20 strain. Nevertheless, employing the optimized defined medium, expression was mainly directed to IBs. In this case, active inclusion bodies represented 57 % of the total aldolase produced. Then, 2L-batch cultivations were performed to characterize the IBs obtained using the optimized defined medium and to produce the necessary amounts for their evaluation as biocatalysts. Cells were grown at 37ºC and FucA production induced by an IPTG pulse of 1 mM when the culture reached 3 units of optical density (OD 600 ). The culture broth was centrifuged and cells harvested (3 g/L final biomass concentration). IBs and soluble intracellular FucA were obtained using lysozyme treatment. An SDS-PAGE showing total, soluble and insoluble fractions is presented in Figure 3 . A pre-induction sample was also included as expression control.
As can be seen in Figure 3 , FucA is mainly produced as IBs. 450 AU/g DCW were found in form of IBs in front of 339 AU/g DCW in the soluble fraction. The specific activity of IB was 8.5 AU/mg FucA. On the other hand, IBs showed a moderate purity of 34% of the total protein, due to the expression vector employed 24 . The obtained IBs suspension was used in further immobilization trials and also as biocatalyst in aldol addition reactions.
Immobilized inclusion bodies as biocatalysts
Active IBs can be employed directly as "self-immobilized" biocatalysts in Results from a IBs Lentikats immobilization experiment are shown in Table 3 . IBs containing 51 AU were immobilized (see Materials and Methods), and 2.9 g of Lentikat® particles were obtained. The activity test of the immobilized derivatives gave 0.53 AU/g of beads, what means an apparent total activity in the lentils of only 1.54 AU (3 % of the original enzymatic load). After two hours of incubation, there was no significant leakage of aldolase activity from the beads (see Table 3 ), showing that IBs size was high enough to avoid exit from the particles. Therefore, the low activity measured in the beads has to be attributed either to a possible enzyme deactivation in the process (not expected at the operating conditions) or, more probably, to an apparent reduction in activity, due to diffusional limitations.
Use of IBs biocatalysts in synthesis
The aldol addition between DHAP and (S)-Cbz-alaninal catalyzed either by direct IBs, Lentikat®-immobilized IBs or soluble FucA, was studied under comparative conditions (the same nominal or assay activity measured with the FucA standard assay). Table 4 shows the results for the initial rate of DHAP disappearance and the reaction yields measured as DHAP conversion degree and product yield after 25 h.
As it can be seen, soluble fraction and IBs exhibit the same initial rate. This is an indication of non diffusional limitations using IBs directly. On the other hand, the Lentikat®-immobilized IBs presented higher initial rate than the corresponding to the nominal activity. This means that most of the offered enzyme activity was really actively immobilized and that diffusional limitations have less influence in the synthesis reaction with non natural substrates than with the natural one employed in the standard assay 30 . Reaction rate is much faster in the assay reaction than in the aldol condensation To sum up, IBs are an interesting alternative to use fuculose-1-phosphate aldolase as biocatalyst because they contain the enzyme in high activity and purity and they could potentially be (re)used efficiently in synthetic reactions. 
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